Walmart settles a long-running federal lawsuit brought by the U.S. Justice Department over allegations that its pharmacies unlawfully dispensed opioids and other controlled substances. The company agrees to pay $50 million, a resolution reported as announced by the DOJ and presented by outlets as avoiding a much larger potential payout.
The lawsuit was filed in 2020. The Justice Department alleges that Walmart pharmacies filled thousands of allegedly invalid prescriptions during the period when the opioid epidemic intensified, including claims that the company failed to report suspicious orders. Several outlets describe the case as part of the federal government’s broader efforts to hold retailers and pharmacists accountable for their role in the opioid crisis.
While all reports focus on the settlement and the alleged dispensing practices, details vary in emphasis: some outlets highlight the scale of invalid prescriptions and orders, others stress the case’s timeline and scope (including operations since 2013). Al Jazeera and others note that the settlement terms are not publicly disclosed beyond the payment amount.
